Study guide
8.1 Perioperative Nursing and Wound Care Management
QCHP/DHP Qualifying Examination - Nurse Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Preparation Strategy
1.1 About the Qatar DHP Nurse Qualifying Exam 1.2 Test-Taking Strategies & Clinical Judgment for Prometric MCQs
2 Chapter 2: Fundamentals of Nursing Practice & Patient Safety
2.1 Infection Prevention, Control, and Aseptic Technique 2.2 Vital Signs, Patient Assessment, and Clinical Documentation 2.3 Patient Safety, Mobility, and Pressure Injury Prevention
3 Chapter 3: Core Nursing Skills: Oxygenation, Nutrition, Elimination & Diagnostics
3.1 Oxygen Delivery, Airway Clearance, and Tracheostomy Care 3.2 Nutrition Screening, Dysphagia, and Feeding-Tube Nursing 3.3 Urinary and Bowel Elimination, Catheter Care, and Ostomy Management 3.4 Specimen Collection, Point-of-Care Testing, and Diagnostic Preparation
4 Chapter 4: Clinical Pharmacology, Calculations & Fluid Balance
4.1 Principles of Safe Medication Administration 4.2 Dosage Calculations and Intravenous Therapy 4.3 Fluid, Electrolyte, and Acid-Base Balance
5 Chapter 5: Adult Cardiovascular, Vascular & Hematologic Nursing
5.1 Acute Coronary Syndromes and Heart Failure Management 5.2 Dysrhythmias, ECG Interpretation, and Shock States 5.3 Peripheral Vascular Disease, Venous Thromboembolism, and Anticoagulation Safety 5.4 Hematology, Anemias, and Blood Component Therapy
6 Chapter 6: Adult Respiratory & Endocrine Nursing
6.1 Chronic and Acute Respiratory Disorders 6.2 Mechanical Ventilation and Critical Respiratory Care 6.3 Diabetes Mellitus and Endocrine Emergencies
7 Chapter 7: Adult Gastrointestinal, Renal & Neurological Nursing
7.1 Gastrointestinal Disorders, Nutrition, and Hepatic Disease 7.2 Renal Disorders, Dialysis, and Fluid Homeostasis 7.3 Neurological Emergencies and Neuromuscular Disorders
8 Chapter 8: Adult Perioperative, Musculoskeletal & Mental Health Nursing
8.1 Perioperative Nursing and Wound Care Management 8.2 Musculoskeletal Care, Trauma, and Burn Management 8.3 Psychiatric and Mental Health Nursing
9 Chapter 9: Adult Oncology, Infectious Disease & Immune Disorders
9.1 Oncology Nursing and Oncologic Emergencies 9.2 Sepsis, Tuberculosis, HIV, and Multidrug-Resistant Organisms 9.3 Immune, Rheumatologic, and Connective Tissue Disorders
10 Chapter 10: Adult Sensory, Integumentary & Gerontological Nursing
10.1 Eye, Ear, and Integumentary Disorders 10.2 Gerontological Nursing and Care of the Older Adult
11 Chapter 11: Pain, Palliative Care & Community Health Nursing
11.1 Pain Management, Palliative Care, and End-of-Life Nursing 11.2 Community, Public Health, and Home Health Nursing
12 Chapter 12: Antepartum & Intrapartum Nursing Care
12.1 Antepartum Health, Prenatal Assessment, and Screening 12.2 Hypertensive Disorders and High-Risk Pregnancy Complications 12.3 Intrapartum Management and Electronic Fetal Monitoring 12.4 Labor Analgesia, Induction, and Operative Birth
13 Chapter 13: Postpartum & Newborn Nursing Care
13.1 Postpartum Assessment, Care, and Complications 13.2 Normal Newborn Assessment and Transition to Extrauterine Life 13.3 High-Risk Neonatal Conditions and Emergency Management
14 Chapter 14: Pediatric Nursing Care
14.1 Pediatric Growth, Development, and Health Promotion 14.2 Pediatric Respiratory and Infectious Illnesses 14.3 Pediatric Fluid, Electrolyte, and Gastrointestinal Disorders
15 Chapter 15: Pediatric Cardiac, Hematologic & Neurologic Conditions
15.1 Pediatric Cardiac and Congenital Heart Disorders 15.2 Pediatric Hematologic and Oncologic Disorders 15.3 Pediatric Neurologic, Musculoskeletal, and Endocrine Conditions
16 Chapter 16: Women's Health & Family-Centered Pediatric Care
16.1 Women's Health, Family Planning, and Gynecologic Care 16.2 Family-Centered Care, Pediatric Medication Safety, and Child Protection
17 Chapter 17: Unit Management, Leadership & Qatar Healthcare Ethics
17.1 Nursing Leadership, Delegation, and Prioritization 17.2 Interprofessional Communication and Patient Safety 17.3 Healthcare Ethics, Legal Practice, and Qatar Regulation
18 Chapter 18: Quality, Staffing & Emergency Preparedness
18.1 Quality Improvement, Risk Management, and Accreditation 18.2 Staffing, Conflict Management, Change Leadership, and Emergency Preparedness
8.1 Perioperative Nursing and Wound Care Management
Key Takeaways Explain This Topic AI
Informed surgical consent is the non-delegable legal responsibility of the operating surgeon to explain risks, benefits, and alternatives; the registered nurse acts solely as a witness to the patient's voluntary signature and mental competency. If the patient expresses uncertainty, misunderstanding, or asks procedural questions, the nurse must withhold the form, withhold sedating premedications, and require the surgeon to return to the bedside before signing.
Preoperative NPO fasting protocols enforce strict minimum intervals: 2 hours for clear liquids, 4 hours for breast milk, 6 hours for infant formula or a light meal, and 8 hours or longer for meals containing meat or fried/fatty foods to prevent pulmonary aspiration of gastric contents (Mendelson syndrome) during anesthesia induction.
The WHO Surgical Safety Checklist mandates three critical pauses: Sign In (prior to induction of anesthesia), Time Out (immediately before skin incision to confirm patient identity, operative site marking, procedure, and prophylactic antibiotic administration within 60 minutes), and Sign Out (prior to leaving the operating room to verify sponge, needle, and instrument counts, specimen labeling, and post-op recovery plans).
Malignant Hyperthermia is an inherited hypermetabolic crisis triggered by volatile halogenated anesthetics (sevoflurane, desflurane, isoflurane) and succinylcholine; an unexplained, rapid rise in End-Tidal CO2 (EtCO2) unresponsive to hyperventilation and resting sinus tachycardia represent the earliest signs, managed by immediately discontinuing triggering agents, ventilating with 100% O2, infusing IV dantrolene sodium (2.5 mg/kg push), active cooling to 38.0°C, and treating hyperkalemia.
Wound evisceration is an acute surgical emergency demanding immediate nursing response: stay with the patient, position in low-Fowler's with knees and hips flexed to relieve abdominal tension, cover protruding viscera immediately with sterile gauze saturated with sterile 0.9% normal saline, never attempt to push organs back into the abdominal cavity, maintain strict NPO status, and notify the surgical team STAT.
Last updated: September 2026
8.1 Perioperative Nursing and Wound Care Management
Perioperative nursing encompasses the continuum of patient care throughout the preoperative, intraoperative, and postoperative phases of surgical intervention. Professional practice requires rigorous adherence to patient safety protocols, profound understanding of surgical pharmacology and anesthesia complications, precise physiological monitoring, and rapid emergency intervention during catastrophic decompensation such as malignant hyperthermia or abdominal wound evisceration.
Preoperative Assessment & Safety Protocols
The preoperative phase commences when the decision for surgical intervention is finalized and concludes when the patient is transferred onto the operating room table. The primary nursing objective is baseline physiological stabilization, risk stratification, and patient safety verification.
The Preoperative Checklist
The preoperative checklist serves as a systematic verification tool to ensure all clinical, diagnostic, and legal prerequisites are satisfied prior to transferring the patient to the operative suite:
Patient Identification: Verify identity using at least two independent identifiers (full legal name, medical record number, and date of birth) matching the hospital wristband against the operative schedule and medical record.
Surgical Site Marking: Confirm that the surgical site has been physically marked with an indelible surgical marker by the operating surgeon (or credentialed surgical designee who will be present during the procedure). The marking must occur in the preoperative holding area while the patient is awake, alert, and capable of participating in site verification. The mark must remain clearly visible after surgical skin antisepsis and sterile draping.
Allergy Verification: Review and document documented allergies, placing high-visibility allergy bands on the patient. Specific inquiry must target:
Latex allergy: Cross-reactivity with tropical fruits (banana, avocado, kiwi, chestnut, passion fruit).
Povidone-iodine / Chlorhexidine allergy: Requires alternative antiseptic skin preparation agents.
Antibiotic allergies: Penicillin/cephalosporin cross-sensitivity dictates alternative surgical prophylaxis.
Physical Preparation & Belongings: Remove all jewelry, body piercings (prevents electrocautery electrical arching and burns), dentures, partial plates, dental bridges (prevents dislodgement and airway occlusion during endotracheal intubation), eyeglasses, contact lenses, hearing aids (retained until immediately prior to induction if required for communication), hairpins, wigs, and nail polish/artificial nails (prevents interference with pulse oximetry light transmission).
Diagnostic & Laboratory Review: Ensure completion and abnormal result reporting for Complete Blood Count (CBC; hemoglobin/hematocrit for oxygen-carrying capacity; platelets for hemostasis), basic metabolic panel (potassium balance critical for cardiac stability during anesthesia), coagulation profile (PT/INR, PTT), blood type and screen or crossmatch, 12-lead ECG (for patients > 40-50 years or with known cardiovascular disease), chest radiograph, and a point-of-care urine or serum human chorionic gonadotropin (hCG) pregnancy test for all females of childbearing potential.
Informed Consent: Legal Principles & Nursing Role
Informed consent is an autonomous, voluntary authorization by the patient permitting a healthcare provider to execute a specific clinical or surgical intervention. Understanding the strict legal boundaries between the provider's duty and the nurse's role is critical on licensure examinations.
Clinical Parameter Operating Surgeon Responsibility Registered Nurse Responsibility
Primary Legal Duty Non-delegable duty to inform and explain all surgical parameters Witness the signature and verify legal prerequisites
Information Required Diagnosis, nature/purpose of procedure, expected benefits, material risks, probability of success, alternative treatments (including no treatment), and prognosis Verify that the patient has received information from the physician and appears competent
Patient Questions Must answer all inquiries regarding procedural technique, alternatives, and surgeon experience If patient expresses questions or doubts, contact surgeon to return to bedside
Signature Execution Obtains the patient's voluntary informed signature Witnesses the patient physically signing the consent document voluntarily
Competence Assessment Assesses cognitive capacity to understand risks and make decisions Confirms patient is alert, oriented, sober, and free from sedating medication
Critical Legal Pitfalls in Informed Consent
Patient Misunderstanding or Hesitation: If the patient states, "I am still not sure why they have to remove my gallbladder," or asks about alternative therapies, the nurse must NOT attempt to explain the surgical procedure, risks, or alternatives . The nurse must withhold the consent form, keep the patient in the holding area, and immediately page the operating surgeon to return to the bedside to re-explain the procedure and answer all patient inquiries before the patient signs.
Timing of Preoperative Sedation: Informed consent MUST be signed PRIOR to the administration of any psychoactive, sedative, or opioid medications (e.g., midazolam, lorazepam, fentanyl, morphine). Any consent document signed after a patient receives sedatives or narcotics is legally null and void due to temporary chemical cognitive impairment. If an unsigned patient has inadvertently received sedation, surgery must be delayed until the medication clears, or consent must be obtained from an authorized legal surrogate or healthcare power of attorney.
Incapacitated Adults & Minors: If an adult patient is legally incompetent or incapacitated, consent must be obtained from the designated durable power of attorney for healthcare, legal guardian, or next of kin in accordance with statutory hierarchy. Minors (< 18 years) require parental or legal guardian consent, except in legally recognized emancipated minors (married, active military duty, or court-emancipated) or state-specific exceptions (emergency care, sexually transmitted infection treatment, contraception, substance abuse treatment).
Emergency Doctrine Exception: In acute life-or-limb-threatening emergencies where the patient is unconscious, cognitively incapacitated, or hemodynamically unstable, and no legal surrogate can be reached despite diligent efforts, the law presumes consent under the principle of beneficence (implied consent). Treatment proceeds immediately to save life or limb; two physicians must document the emergent necessity in the medical record.
Evidence-Based Fasting (NPO) Guidelines
Preoperative fasting protocols are designed to minimize residual gastric fluid volume and acidity, thereby preventing regurgitation and life-threatening pulmonary aspiration of gastric contents (Mendelson syndrome) during the induction of anesthesia and endotracheal intubation. Preoperative NPO Fasting Hierarchy (ASA Standards):
- 2 Hours: Clear liquids only (water, fruit juice without pulp, black coffee, clear tea)
- 4 Hours: Ingested human breast milk
- 6 Hours: Infant formula, non-human animal milk, light meal (toast & clear liquid)
- 8+ Hours: Fried foods, fatty foods, or meals containing meat
Clear Liquids (Minimum 2-Hour Fast): Patients may consume clear liquids up to 2 hours prior to scheduled anesthesia induction. Clear liquids include water, clear fruit juices without pulp (apple juice, white grape juice), clear broth, black coffee (strictly no milk or cream), plain tea, and carbonated beverages. Current evidence demonstrates that maintaining clear liquid hydration up to 2 hours preoperatively reduces patient thirst, anxiety, dehydration, and postoperative nausea without increasing gastric volume.
Breast Milk (Minimum 4-Hour Fast): Neonates and infants require a minimum 4-hour fasting period following ingestion of breast milk due to rapid gastrointestinal transit.
Infant Formula & Light Meals (Minimum 6-Hour Fast): Infant formula, non-human milk (cow's milk contains casein, forming gastric curds that delay emptying), and a light meal (such as plain white toast and clear liquid) mandate a minimum 6-hour fasting interval.
Fatty, Fried, or Meat Meals (Minimum 8-Hour Fast): Meals containing fried items, high lipid content, or animal meats significantly prolong gastric emptying time, mandating an absolute minimum fasting period of 8 hours or longer.
Preoperative Medication Adjustments
Managing routine chronic medications prior to surgery requires balancing the risk of perioperative withdrawal or disease decompensation against the hazards of surgical hemorrhage, hypotension, and drug interactions:
Anticoagulants and Antiplatelets:
Warfarin: Withhold 5 days prior to elective surgery; target preoperative International Normalized Ratio (INR) is <= 1.5. If emergency reversal is mandated, administer Vitamin K (phytonadione) and 4-factor Prothrombin Complex Concentrate (PCC) or Fresh Frozen Plasma (FFP).
Direct Oral Anticoagulants (DOACs - Apixaban, Rivaroxaban, Dabigatran): Withhold 48 to 72 hours prior to surgery, adjusted upward for renal impairment.
Clopidogrel (Plavix) & Ticagrelor: Withhold 5 to 7 days prior to elective procedures to restore platelet aggregation.
Aspirin: Typically discontinued 7 days prior to procedures involving closed spaces (intracranial, spinal, posterior eye surgery); often continued in patients with recent drug-eluting coronary stents undergoing non-cardiac surgery.
NSAIDs (Ibuprofen, Naproxen): Withhold 48 hours to 7 days depending on elimination half-life.
Cardiovascular Medications:
Beta-Blockers (Metoprolol, Atenolol): CONTINUE on the morning of surgery with a minimal sip of water! Abrupt withdrawal causes rebound sympathetic hyperactivity, tachycardia, hypertension, and marked increases in perioperative myocardial infarction and mortality.
ACE Inhibitors (Lisinopril) and ARBs (Losartan): WITHHOLD on the morning of surgery . Concomitant administration with general anesthetics induces profound, refractory intraoperative vasoplegic hypotension that is notoriously unresponsive to conventional alpha-1 adrenergic agonists (phenylephrine), often requiring vasopressin or methylene blue rescue.
Endocrine & Diabetic Medications:
Oral Hypoglycemics: Withhold on the morning of surgery. Withhold Metformin 48 hours prior if IV iodinated radiocontrast media will be administered to eliminate the risk of lactic acidosis. Withhold SGLT2 inhibitors (Empagliflozin, Dapagliflozin) 3 to 4 days prior to prevent perioperative euglycemic diabetic ketoacidosis (euDKA).
Insulin Regimens: Withhold morning rapid-acting (lispro, aspart) or regular insulin because the patient is fasting. Administer a reduced dose (typically 50% to 80%) of the patient's intermediate-acting (NPH) or long-acting basal insulin (glargine, detemir) on the morning of surgery to prevent ketogenesis. Perform point-of-care capillary blood glucose checks every 2 to 4 hours; initiate an IV regular insulin infusion for glycemic targets (140 to 180 mg/dL).
Herbal Supplements (The "4 Gs"):
Garlic, Ginkgo Biloba, Ginseng, and Ginger: All potentiate platelet inhibition and increase intraoperative bleeding risk. All herbal products must be discontinued at least 2 weeks prior to elective surgery.
St. John's Wort: Induces hepatic cytochrome P450 enzymes, accelerating the metabolism of anesthetic agents, sedatives, and opioids.
Intraoperative Safety & Malignant Hyperthermia Emergency
The intraoperative phase begins upon entry into the operating room and extends until transfer to the post-anesthesia care unit (PACU). Intraoperative nursing emphasizes sterile asepsis, surgical counts, physiological surveillance, and immediate coordinated crisis management.
The WHO Surgical Safety Checklist
The World Health Organization (WHO) Surgical Safety Checklist establishes a standardized, three-phase communication protocol proven to drastically reduce perioperative morbidity, mortality, and wrong-site surgical errors: WHO Surgical Safety Checklist: Three Mandatory Checkpoints
1. SIGN IN (Before Anesthesia Induction): Patient confirms ID, site, consent; allergy/airway check.
2. TIME OUT (Before Skin Incision): Full team pause; verify patient, site, procedure, antibiotics.
3. SIGN OUT (Before Leaving OR): Instrument/sponge counts, specimen labeling, post-op concerns.
Sign In (Prior to Anesthesia Induction): Conducted collaboratively by the circulating nurse and anesthesia provider with the patient participating:
Confirm patient identity, surgical site marking, procedure, and signed informed consent.
Check anesthesia machine, monitors, and medication emergency drugs.
Confirm functional pulse oximeter placement.
Verify patient allergy status, anticipated difficult airway or aspiration risk, and risk of massive blood loss (> 500 mL in adults or > 7 mL/kg in children); confirm availability of two large-bore IVs and crossmatched blood products.
Time Out (Immediately Prior to Skin Incision): A mandatory, formal pause where all operating room activities cease completely , involving the entire multidisciplinary surgical team (surgeon, anesthesia provider, scrub nurse/technician, circulating nurse):
All team members introduce themselves by name and professional role.
Verify correct patient, correct operative procedure, and correct anatomical site and side.
Confirm that prophylactic IV antibiotics have been completely infused within 60 minutes prior to surgical incision (or within 120 minutes for vancomycin and fluoroquinolones) to establish peak bactericidal tissue concentrations.
Confirm that essential diagnostic radiographs, MRI, or CT images are properly displayed.
Surgeon reviews anticipated critical steps, operative duration, and anticipated blood loss.
Anesthesia provider reviews specific patient hemodynamic concerns or airway vulnerabilities.
Nursing team confirms sterility indicators, equipment availability, and implant verifications.
Sign Out (Prior to Patient Transfer Out of the Operating Room): Conducted before the surgeon leaves the room:
Circulating nurse verbally confirms the recorded name of the completed surgical procedure.
Confirm completion and accuracy of sponge, needle, sharp, and instrument counts . Any discrepancy requires immediate recount, wound exploration, and intraoperative plain radiography before wound closure.
Confirm correct verbal reading and labeling of pathology specimens (patient name, identification number, anatomical source).
Identify any malfunctioning equipment or clinical equipment issues.
Multidisciplinary review of critical postoperative management concerns, PACU recovery trajectory, hemodynamic goals, and airway vulnerabilities.
Malignant Hyperthermia (MH): Pathophysiology & Emergency Protocol
Malignant Hyperthermia is a rare, pharmacogenomic, life-threatening hypermetabolic crisis of skeletal muscle triggered by exposure to specific anesthetic agents. It occurs predominantly in individuals carrying an autosomal dominant mutation in the RYR1 (ryanodine receptor 1) gene or the CACNA1S (voltage-gated calcium channel) gene.
Pharmacological Triggers
Volatile Halogenated Inhalational Anesthetics: Sevoflurane, Desflurane, Isoflurane, Halothane, and Enflurane.
Depolarizing Neuromuscular Blocking Agent: Succinylcholine .
Safe Non-Triggering Agents: Nitrous oxide, IV anesthetics (Propofol, Etomidate, Ketamine), opioids, benzodiazepines, local anesthetics (Lidocaine, Bupivacaine), and non-depolarizing neuromuscular blockers (Rocuronium, Vecuronium, Cisatracurium).
Molecular Pathophysiology
Triggering agents induce uncontrolled, sustained calcium ( C a 2 + Ca^{2+} C a 2 + ) efflux from the sarcoplasmic reticulum into the myoplasm via mutated, hyperactive ryanodine receptors. Intracellular calcium accumulation overwhelms the sarcoplasmic reticulum calcium ATPase pump (SERCA), activating continuous, unregulated actin-myosin cross-bridging and intense skeletal muscle contractions. This produces a massive surge in aerobic and anaerobic metabolism, extreme oxygen consumption, profound lactic acidosis, excessive carbon dioxide ( C O 2 CO_2 C O 2 ) production, and vast heat generation. Depleted ATP causes myocyte membrane collapse, releasing intracellular potassium, myoglobin, and creatine kinase into systemic circulation.
Clinical Manifestations: Early vs. Late Signs
Earliest & Most Sensitive Sign: Unexplained, rapid, precipitous rise in End-Tidal Carbon Dioxide ( E t C O 2 EtCO_2 EtC O 2 ) (often exceeding 60 to 80+ mmHg) that is completely refractory to marked increases in mechanical minute ventilation.
Cardiovascular: Persistent sinus tachycardia (earliest physical vital sign as catecholamines surge), labile blood pressure, and cardiac dysrhythmias (ventricular ectopy, peaked T waves from acute hyperkalemia).
Muscular: Masseter muscle spasm / rigidity (trismus) immediately following succinylcholine administration; progressing to generalized board-like "wooden" muscle rigidity.
Metabolic: Severe mixed respiratory and metabolic lactic acidosis (arterial pH < 7.15, base deficit > -10 mEq/L), tachypnea, mottled cyanotic skin.
Late, Grave Sign: Extreme Hyperthermia . Core body temperature rises rapidly at a rate of 1°C to 2°C every 5 minutes , frequently reaching or exceeding 40°C to 42°C (104°F to 107.6°F) . Hyperthermia is a late confirmatory sign; waiting for elevated temperature before treating guarantees severe neurological injury or death!
Post-Crisis Sequelae: Massive rhabdomyolysis releases myoglobin into circulation, manifesting as tea-colored or dark reddish-brown urine ( myoglobinuria ) and severe acute renal tubular necrosis, accompanied by marked elevation of serum Creatine Kinase (CK > 10,000 to 100,000 U/L) and hyperkalemic cardiac arrest.
Emergency Malignant Hyperthermia Protocol
When malignant hyperthermia is recognized, the team must execute the following protocol simultaneously:
Immediately Halt Triggering Agents: Cease administration of all volatile anesthetics (turn off vaporizers) and succinylcholine immediately. Notify the surgical team; terminate or expedite surgical closure. Do not waste time changing the anesthesia circuit; insert activated charcoal filters into both limbs of the circuit or hyperventilate on high flow.
Hyperventilate with 100% Oxygen: Administer 100% pure oxygen at maximum fresh gas flows (>= 10 to 15 L/min) and increase minute ventilation 2 to 3 times the baseline to flush accumulating carbon dioxide.
Administer IV Dantrolene Sodium STAT:
Dantrolene is the specific, life-saving antidote that directly binds the RYR1 ryanodine receptor, halting calcium release from the sarcoplasmic reticulum into the sarcoplasm.
Dosing: Initial bolus of 2.5 mg/kg rapid IV push . Repeat 2.5 mg/kg bolus every 5 to 10 minutes until muscle rigidity subsides, heart rate slows, and E t C O 2 EtCO_2 EtC O 2 normalizes. Doses up to 10 mg/kg (and occasionally up to 20-30 mg/kg) may be required in severe crises.
Formulations: Ryanodex (nanocrystal formulation: 250 mg/vial reconstitutes in 5 mL sterile water in under 1 minute); classic Dantrium/Revonto (20 mg/vial requires 60 mL sterile water per vial, requiring several staff members to dissolve 20-30 vials).
Active Core & Surface Cooling:
Infuse chilled, cold IV 0.9% Normal Saline (4°C) at 1,000 mL every 10 to 15 minutes.
Apply ice packs to high-vascularity zones: bilateral axillae, groin, and neck.
Perform iced normal saline lavages of the stomach (via NG tube), urinary bladder (via 3-way Foley), and open peritoneal cavity if accessible.
CRITICAL TEMPERATURE CEILING: Halt active cooling measures when core body temperature drops to 38.0°C (100.4°F) to prevent severe, inadvertent rebound hypothermia and cardiac dysrhythmias.
Correct Hyperkalemia & Severe Acidosis:
Administer IV Sodium Bicarbonate (1 to 2 mEq/kg) to buffer severe metabolic acidosis and facilitate intracellular potassium shifts.
For hyperkalemia: Administer IV Regular Insulin (10 units) with 50% Dextrose (50 mL) to drive potassium into cells, accompanied by IV Calcium Chloride (10% solution, 10 mL) or Calcium Gluconate (10% solution, 30 mL) to stabilize cardiac myocyte membranes against fatal dysrhythmias.
Maintain Diuresis & Renal Protection: Administer IV fluids, mannitol, or furosemide to maintain an active urine output of >= 2 mL/kg/hr to flush myoglobin casts from renal tubules and prevent obstructive acute kidney injury.
Intensive Care Transfer: Transfer to the ICU for continuous hemodynamic, electrolyte, and temperature monitoring for a minimum of 24 to 48 hours due to a 25% risk of crisis recrudescence within 24 hours.
Postoperative Recovery, PACU Care & Pulmonary Complications
The postoperative phase begins with PACU admission and concludes upon full resolution of surgical recovery. Immediate priorities focus on airway patency, cardiovascular stability, pain control, and early mobilization.
The Modified Aldrete Scoring System
The Modified Aldrete Score is the universally recognized clinical scoring tool utilized to evaluate readiness for discharge from the PACU to an inpatient surgical ward. Five physiological parameters are assessed, each scored from 0 to 2, yielding a maximum score of 10:
Assessment Domain 2 Points 1 Point 0 Points
Activity Able to move 4 extremities voluntarily or on command Able to move 2 extremities voluntarily or on command Unable to move extremities / 0 extremities
Respiration Able to breathe deeply and cough freely Dyspneic, shallow, or limited breathing Apneic or airway obstructed
Circulation BP within ± \pm ± 20% of pre-anesthesia baseline BP within ± \pm ± 20% to 50% of baseline BP deviates > 50% from baseline
Consciousness Fully awake and oriented Arousable on verbal calling Completely unresponsive
Oxygen Saturation Maintains S p O 2 SpO_2 Sp O 2 > 92% on ambient room air Requires supplemental O 2 O_2 O 2 to maintain S p O 2 SpO_2 Sp O 2 > 90% S p O 2 SpO_2 Sp O 2 < 90% despite supplemental O 2 O_2 O 2
Discharge Threshold: A minimum score of >= 8 out of 10 (with 2 points in Respiration) is universally required for safe discharge from Phase I PACU to an inpatient med-surg unit, provided surgical site bleeding is minimal and vital signs are stable.
Common PACU Complications & Nursing Management
Postoperative Urinary Retention (POUR): Inability to void following catheter removal or surgery, caused by lingering spinal/epidural blockade (S2-S4 parasympathetic inhibition), high-dose systemic opioids, anticholinergics, and pelvic manipulation. If the patient has not voided within 6 to 8 hours postoperatively or reports suprapubic fullness, perform a bedside bladder ultrasound scan . If retained urine volume exceeds 400 to 500 mL , perform straight in-and-out catheterization under aseptic technique.
Hypothermia & Shivering: Anesthetic-induced vasodilation and cold operating room temperatures induce hypothermia (core temp < 36.0°C). Shivering dramatically increases metabolic rate, oxygen consumption by up to 400%, and myocardial work. Intervene with forced-air warming blankets (Bair Hugger) and warm IV fluids; administer low-dose IV Meperidine (Demerol 12.5 to 25 mg) to rapidly suppress shivering thermogenesis.
Atelectasis & Pulmonary Prophylaxis:
Anesthesia, surgical recumbency, and splinted shallow breathing cause micro-alveolar collapse, making atelectasis the most common cause of postoperative low-grade fever within the first 24 to 48 hours .
Incentive Spirometry Protocol: Patient sits upright in high-Fowler's position, exhales completely, seals lips firmly around mouthpiece, inhales slowly and deeply to maximally elevate the piston, holds breath for 3 to 5 seconds at peak inspiration, and exhales passively. Perform 10 breaths every hour while awake .
Controlled Coughing with Incisional Splinting: Teach the patient to firmly press a folded pillow or blanket over the abdominal incision while coughing deeply to stabilize fascial margins and minimize pain.
Early Ambulation: The single most effective, evidence-based intervention to expand lung bases, stimulate peristalsis (preventing paralytic ileus), and prevent deep vein thrombosis.
Wound Healing Trajectories & Emergency Complications
Surgical wounds heal through distinct physiological mechanisms depending on the extent of tissue loss and microbial contamination.
The Three Intentions of Wound Healing
Healing Modality Tissue Characteristics Mechanism of Closure Clinical Scenarios & Outcomes
Primary Intention Minimal tissue loss; clean, sterile margins Surgical incision edges are directly approximated using sutures, surgical staples, or skin adhesive Surgical laparotomy, elective laceration repair; rapid healing within days; minimal granulation tissue; fine, hairline cosmetic scar
Secondary Intention Significant tissue loss; irregular edges; severe contamination Edges cannot be approximated; wound is left open to heal from base upward via extensive granulation tissue and wound contraction Stage 3-4 pressure injuries, infected open surgical wounds, decubitus ulcers; prolonged healing; high infection risk; large, prominent scarring
Tertiary Intention (Delayed Primary) Heavily contaminated, edematous, or infected wound Wound is deliberately left open with moist sterile packing for 3 to 5 days for drainage, then surgically closed once clean Perforated appendicitis, contaminated traumatic wounds, open fasciotomy; combines secondary granulation with subsequent primary closure
Phases of Wound Healing
Hemostasis (Immediate to Hours): Platelet aggregation, vasoconstriction followed by vasodilation, fibrin clot lattice deposition.
Inflammatory Phase (Day 1 to Day 4): Neutrophil recruitment followed by macrophages clearing necrotic debris, bacteria, and synthesizing growth factors. Manifests with localized erythema, mild edema, warmth, and moderate serosanguinous exudate.
Proliferative Phase (Day 4 to Day 21): Fibroblasts synthesize collagen and ground substance; capillary budding creates bright red, vascular, granular "beefy" tissue ( granulation tissue ); myofibroblasts mediate wound margin contraction, followed by epithelial resurfacing.
Maturation / Remodeling Phase (Day 21 to 1-2 Years): Type III collagen is systematically replaced by dense, organized Type I collagen along stress lines. Scar tissue pales, contracts, and strengthens, ultimately achieving a maximum tensile strength of approximately 80% of original intact unwounded skin .
Wound Dehiscence vs. Wound Evisceration
Wound Dehiscence: Partial or complete separation of the fascial or cutaneous margins of a surgical incision without protrusion of internal visceral organs. The classic warning sign is a sudden, copious gush of clear, serosanguinous fluid from the incision between postoperative days 5 and 10 (the vulnerable nadir where suture holding strength declines before mature collagen forms).
Wound Evisceration: Complete disruption of all surgical wound layers (skin, subcutaneous fat, musculofascial sheath, and peritoneum) accompanied by the extrusion and protrusion of internal visceral organs (typically small intestine) through the wound defect. This is a catastrophic, life-threatening surgical emergency.
Precipitating Triggers: Forceful coughing, sneezing, vomiting, straining against constipation (Valsalva), lifting, abdominal distension, severe malnutrition (hypoalbuminemia < 3.0 g/dL), obesity, diabetes mellitus, and chronic systemic corticosteroid therapy. Immediate Emergency Response: Abdominal Wound Evisceration
1. STAY WITH THE PATIENT - Call for emergency nursing assistance immediately.
2. POSITION: Low-Fowler's with hips and knees flexed to reduce abdominal wall tension.
3. COVER: Place sterile gauze soaked in sterile 0.9% normal saline over exposed viscera.
4. DO NOT REINSERT: Never push or force protruding organs back into the abdominal cavity.
5. ENFORCE NPO: Withhold all oral intake; prepare for emergency exploratory laparotomy.
6. NOTIFY STAT: Contact attending surgeon and operating room team immediately.
7. MONITOR VITAL SIGNS: Assess for impending hypovolemic/septic shock every 5-10 minutes.
Detailed Step-by-Step Evisceration Protocol
Stay with the Patient: Never abandon the patient. Call loudly for colleague assistance and pull the emergency call light. Instruct colleagues to notify the attending surgeon STAT, alert the operating room, and bring the sterile dressing cart and IV supplies.
Positioning: Immediately adjust the bed to place the patient in Low-Fowler's position with the head of the bed elevated 15 to 30 degrees and the knees and hips flexed (semi-Fowler's with knees bent using pillows under the knees). This posture relaxes the rectus abdominis muscles, markedly reducing intra-abdominal tension and preventing further visceral exteriorization.
Cover the Exposed Organs with Sterile Saline-Moistened Dressings: Immediately open sterile surgical packs and generously soak sterile abdominal laparotomy pads or gauze towels with sterile 0.9% Normal Saline . Gently drape the saturated sterile towels over the entire wound and protruding intestinal loops.
Pathophysiological Rationale: Prevents desiccation, ischemic necrosis, and hypothermia of the fragile peritoneal serosa and bowel wall, while providing a sterile barrier against ambient hospital pathogens.
Maintenance: Continuously moisten the dressing with sterile saline if prolonged transport occurs; never allow the gauze to dry out, as dry gauze adheres to serosa and peels bowel wall when removed.
CRITICAL PROHIBITION - Do NOT Attempt Reinsertion: Never attempt to push, manipulate, or re-insert the protruding visceral organs back into the abdominal cavity! Manual pressure forces contaminated bowel into a sterile peritoneal space, introduces lethal peritonitis, strangulates mesenteric blood supply, and risks bowel perforation.
Maintain Strict NPO Status: Enforce complete fasting. Withhold all oral liquids, medications, and ice chips. If gastric distension or active vomiting occurs, place a nasogastric tube to low continuous suction under surgical orders to decompress the stomach.
Hemodynamic Stabilization & Shock Monitoring: Obtain baseline vital signs immediately and repeat every 5 to 10 minutes. Protruding viscera allows massive fluid evaporation and third-space fluid sequestration, predisposing to hypovolemic and neurogenic shock (tachycardia, hypotension, pallor, cold diaphoresis). Ensure two large-bore peripheral IV cannulas (16- or 18-gauge) are patent and infuse prescribed isotonic crystalloids.
Patient Reassurance & Calming: Reassure the patient in a calm, authoritative voice. Instruct the patient to take slow, deep breaths through the mouth and avoid coughing, crying, or straining. Keep a light blanket over the patient's upper chest and lower legs to prevent systemic hypothermia while avoiding pressure on the abdomen.